Effect of Vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5

Polskie Archiwum Medycyny Wewnetrznej

Volumn 125, Issue 9, 2015, Pages 631-640

  Kurnatowska, Ilona ^a   Grzelak, Piotr ^a   Masajtis Zagajewska, Anna ^a   Kaczmarska, Magdalena ^a   Stefañczyk, Ludomir ^a   Vermeer, Cees ^b   Maresz, Katarzyna ^c   Nowicki, Michal ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c International Science and Health Foundation   (Poland)

Author keywords

Atherosclerosis; Chronic kidney; Disease; Vascular calcification; Vitamin K2

Indexed keywords

COLECALCIFEROL; FARNOQUINONE; FETUIN A; FIBROBLAST GROWTH FACTOR 23; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MENAQUINONE; OSTEOCALCIN; OSTEOPROTEGERIN; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LOW DRUG DOSE; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; AGED; CAUCASIAN; DIETARY SUPPLEMENT; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZATION; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CALCIFICATION;

ADULT; AGED; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CALCIFICATION; VITAMIN K 2;

EID: 84943630381     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.3041     Document Type: Article

References (31)

1. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
2. London GM, Marchais SJ, Guerin A P, Metivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens. 2005; 14: 525-531.
3. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007; 20: 103-109.
4. Shanahan CM. Vascular calcification. Curr Opin Nephrol Hypertens. 2005; 14: 361-367.
5. Spronk HM, Soute BA, Schurgers LJ, et al. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of arterial vessel wall. Biochem Biophys Res Commun. 2001; 289: 485-490.
6. Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein. Nephrology. 2006; 11: 455-461.
7. Schurgers LJ, Spronk HM, Skepper JN, et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Hemost. 2007; 5: 2503-2511.
8. Thijssen HH, Drittij-Reijnders MJ. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone. Br J Nutr. 1996; 75: 121-127.
9. Schurgers LJ, Teunissen KJ, Knapen MH, et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as a marker for vascular calcification. Arterioscler Thromb Vasc Biol. 2005; 25: 1629-1633.
10. Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009; 203: 489-493.
11. Razzaque MS. The dualistic role of vitamin D in vascular calcifications. Kidney Int. 2011; 79: 708-714.
12. Holden RM, Morton AR, Garland JS, et al. Vitamins K and D status in stage 3-5 Chronic Kidney Disease. Clin J Am Soc Nephrol. 2010; 5: 590-597.
13. Aminbakhsh A, Mancini GB. Carotid intima media thickness measurements. What defines an abnormality? A systemic review. Clin Invest Med. 1999; 22: 149-157.
14. Papagianni A, Kalovoulos M, Kirmizis D, et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant. 2003; 18: 113-119.
15. Gast GC, de Roos NM, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009; 19: 504-510.
16. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994; 93: 2393-2402.
17. Shea MK, O'Donnell CJ, Hoffmann U, et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr. 2009; 89: 1799-1807.
18. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1599-1605.
19. McCullough PA, Agrawal V, Danielewicz E, Abela GS. Accelerated atherosclerotic calcification and Mönckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1585-1598.
20. Kurnatowska I, Grzelak P, Stefanczyk L, Nowicki M. Tight relations between coronary calcification and atherosclerotic lesions in the carotid artery in chronic dialysis patients. Nephrology. 2010; 15: 184-189.
21. Młynarska A, Młynarski R, Sosnowski M. Effect of coronary artery calcium score on the reduction of global cardiovascular risk. Pol Arch Med Wewn. 2014; 124:88-96.
22. Shroff RC, McNair R, Figg N, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008; 118: 1748-1757.
23. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009; 94: 45-49.
24. Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with iban-dronate. Kidney Int. 2006; 70: 1577-1583.
25. Parker BD, Bauer DC, Ensrud KE, Ix JH. Association of osteocalcin and abdominal aortic calcification in older women: the study of osteoporotic fractures. Calcif Tissue Int. 2010; 86: 185-191.
26. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998; 12: 1260-1268.
27. Katsuyama H, Otsuki T, Tomita M, et al. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med. 2005; 15: 231-236.
28. Sasaki N, Kusano E, Takahashi H, et al. Vitamin K2 inhibits glucocorti-coid-induced bone loss partly by preventing the reduction of osteoproteger-in (OPG). J Bone Miner Metab. 2005; 23: 41-47.
29. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol. 2001; 21: 1610-1616.
30. Nagasawa Y, Fujii M, Kajimoto Y, et al. Vitamin K2 and serum cholesterol in patients on continuous ambulatory peritoneal dialysis. Lancet. 1998; 351: 724.
31. Russo D, Corrao S, Miranda I, et al. Progression of coronary artery calcification in predialysis patients. Am J Nephrol. 2007; 27: 152-158.